(Objective) The objective of this study was to elucidate the efficacy of short-term therapy with a polymeric formula (Racol
®) in patients with active Crohn's disease (CD).
(Subjects) There were 11 patients with active CD who were administered enteral nutrition therapy and who consented to receive the therapy with polymeric formula (Racol
®). Out of the 11 patients, 3 patients dropped out and 8 patients were included to be analyzed.
(Method) After continual administration of Racol
® for 6 weeks, the remission rate by Crohn's Disease Activity Index (CDAI) was determined. C-reactive protein (CRP), erythrocyte sedimentation rate and blood albumin were also measured. X-ray findings were graded using a score system and the scores of post-therapy were compared with those of pre-therapy. In addition, fractionated blood fatty acids were measured and the ratio of n-3 fatty acid to n-6 fatty acid (n-3/n-6 ratio) was compared.
(Results) The remission rate by CDAI was 87.5% (7/8 subjects). CRP, erythrocyte sedimentation rate, blood albumin and X-ray finding scores were also significantly improved between pre-EN therapy and post-EN therapy. There was no difference in n-3/n-6 ratio between pre-EN therapy and post-EN therapy.
(Conclusion) The results of this study suggest that the short-term therapy with polymeric formula diet (Racol
®) could be effective in patients with active CD.
View full abstract